multivitamin-, mineral-, and n-3 fatty acids supplementation is effective in aggression reduction in chronic psychiatric inpatients.
ID
Bron
Aandoening
chronic psychiatric inpatients
aggression
nutrition
n3-fatty acids
vitamins
minerals
langdurig opgenomen psychiatrisch patienten
agressie
voeding
n3-essentiele vetzuren
vitaminen
mineralen
Ondersteuning
Atrium Innovations Inc.
Leids Universitair Medisch Centrum
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The main parameter in this study is the number of aggressive incidents in each arm, registered with the Staff Observation Aggression Scale- Revised Version (SOAS-R) (Nijman et al., 1999). As incidents may differ in severity and consequences, we make a distinction between minor (verbal aggression, threats, non-compliance with hospital rules, aggression towards objects, disinhibited [sexual] behaviour) and major (severe threats, fighting, assault on patients or staff, self-harm, suicide attempt) incidents. We carried out a pilot study to determine the prevalence of aggressive incidents among long-term psychiatric inpatients. This study yielded an estimate of 112 incidents per patient per year: 65 verbal aggression incidents, 12 incidents in which aggression was aimed at objects, 8 self-harm incidents, and 27 incidents in which physical aggression was aimed at others. We also monitored the time spent by nursing staff on each of these four types of incidents; verbal aggression took 80 minutes, aggression towards objects cost 77 minutes, self-harm cost 222 minutes, and physical aggression towards others cost 335 minutes per incidents. Based on these results, major incidents will be weighted by a factor 3.8.
Doel van het onderzoek
multivitamin-, mineral-, and n-3 fatty acids supplementation is effective in aggression reduction in chronic psychiatric inpatients.
Onderzoeksopzet
SOAS-r will be used continuaously throuhghout the trial to register aggressive incodents.
t0, baseline: blood sampling (to monitor compliance), AVL-AV, SDAS, vCPRS, WHOQL-bref
t1, 2 weeks: SDAS
t3, 2 months: AVL-AV, SDAS, vCPRS, WHOQL-bref
t4, 6 months: blood sampling (to monitor compliance), AVL-AV, SDAS, vCPRS, WHOQL-bref
Onderzoeksproduct en/of interventie
During the six-month intervention, one group will receive two daily supplements :
• Orthica Soft Multi, containing vitamins (B1, B2, B3, B5, B6, B11, B12, C, D, E, Beta Carotene) and minerals (Calcium, Iodine, Copper, Magnesium, Selenium, Iron, Zinc, Potassium, Chrome, Manganese).
• Orthica Fish EPA MAX, containing n-3FA (EPA and DHA).
Both supplements are soft gel capsules and are available to the general public without prescription. Both supplements can be used as an addition to the existing diet. Patients can continue their normal dietary pattern and use of medication. The other group will receive two placebo capsules daily. Both supplements and placebos will be distributed through patients’ Baxters, which are filled by the local pharmacist.
Publiek
Anke Schat
Postbus 9600
Leiden 2300 RC
The Netherlands
0715262552
a.schat@lumc.nl
Wetenschappelijk
Anke Schat
Postbus 9600
Leiden 2300 RC
The Netherlands
0715262552
a.schat@lumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
age 18 or older
residing at a facility for long-term psychiatric care
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
pregnancy
breastfeeding
known contra indication for treatment with the supplements used in this study
expected discharge or transfer within the next eight weeks
current use of nutritional supplements and unwillingness to quit
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5030 |
NTR-old | NTR5176 |
CCMO | NL51850.058.14 |
OMON | NL-OMON47917 |